Systemic anaphylaxis caused by moxifloxacin.
Sánchez-Morillas
L
L
Rojas Pérez-Ezquerra
P
P
Reaño-Martos
M
M
Laguna-Martínez
J J
JJ
Gómez-Tembleque
P
P
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000707:Anaphylaxis; D000799:Angioedema; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D000075202:Contraindications; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D015242:Ofloxacin / Q000627:therapeutic use; D011537:Pruritus; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012867:Skin / Q000276:immunology / Q000473:pathology*; D012882:Skin Tests; D014581:Urticaria
D000305:Adrenal Cortex Hormones; D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D015242:Ofloxacin; D000077266:Moxifloxacin